| Basic data |
|---|
| OCA1. Surname awarded to the assessed person | Mojžišová Vaščinec |
|---|
| OCA2. Name awarded to the assessed person | Jana |
|---|
| OCA3. Degrees awarded to the assessed person | Dr. h. c. Prof. , DVM, PhD |
|---|
| OCA4. Hyperlink to the entry of the person in the Register of university staff | https://www.portalvs.sk/regzam/detail/6013 |
|---|
| OCA5. Area of assessment | study programme general veterinary medicine · I. + II. degree |
|---|
| OCA6. Category of the research/artistic/other output | scientific output |
|---|
| OCA7. Year of publication of the research/artistic/other output | 2024 |
|---|
| OCA8. ID of the record in the Central Registry of Publication Activity (CRPA) or the Central Registry of Artistic Activity (CRAA) | |
|---|
| OCA9. Hyperlink to the record in CRPA or CRAA | https://app.crepc.sk/?fn=detailBiblioFormChildU12O5K&sid=9A77F24CB1252B04C7D6500220F3&seo=CREP%C4%8C-detail-%C4%8Cl%C3%A1nok |
|---|
| Characteristics of the output that is not registered in CRPA or CRAA |
|---|
| OCA10. Hyperlink to the record in another publicly accessible register, catalogue of research/ artistic/other outputs | https://arl4.library.sk/arl-uvlk/sk/detail-uvlk_un_cat-0043703-Investigation-of-canine-parvovirus-occurrence-in-cats-with-clinical-signs-of-feline-panleukopenia-in/?disprec=1&iset=13 |
|---|
| OCA11. Characteristics of the output in the format of the CRPA or the CRAA bibliographic record, if the output is not available in a publicly accessible register or catalogue of outputs | CITAROVÁ, Alexandra - MOJŽIŠOVÁ, Jana - PETROUŠKOVÁ, Patrícia - PELEGRINOVÁ, Andrea - KOSTIČÁK, Maroš - KORYTÁR, Ľuboš - PROKEŠ, Marián - VOJTEK, Boris - ONDREJKOVÁ, Anna - DRÁŽOVSKÁ, Monika. Investigation of canine parvovirus occurrence in cats with clinical signs of feline panleukopenia in Slovakia – pilot study. In: Journal of Veterinary Research. 2024. ISSN 2450-7393, Vol. 68, DOI : 10.2478/jvetres-2024-0021 (2024), p. [1-7]
(2022: 1.800 - IF, 30 - H-index, 2.200 - IF 5y, 0.409 - SJR, Q2 - SJR Best Q, Q2 - JCR Best Q) |
|---|
| OCA12. Type of the output (if the output is not registered in CRPA or CRAA) | article |
|---|
| OCA13. Hyperlink to the webpage where the output is available (full text, other documentation, etc.) | |
|---|
| OCA14. Characteristics of the author's contribution | The author is the owner of the conceptual plan of the publication, she participated in the experimental part, the intrepretation of the results and in the final form of the publication. |
|---|
| OCA15. Annotation of the output with contextual information concerning the description of creative process and the content of the research/artistic/other activity, etc. | This study aimed to determine the presence of CPV-2 in cats with signs of
FPL in Slovakia and to investigate the suitability of a CPV antigen test for detection of FPV. The study was conducted on samples from central Slovakia collected from October 2020 to December 2022. Cats were either from animal shelters or admitted to veterinary clinics for treatment because they presented FPL symptoms. Cats were initially screened for the presence of parvovirus antigens using a chromatographic immunological antigen (Ag)test for CPV and canine coronavirus (CCV). All samples
were investigated for parvovirus infection by PCR
targeting the VP2 gene (1,755 base pairs). Our results indicate that the commercial antigen test designed for the diagnosis of CPV-2 infection is
sensitive enough and suitable for the clinical diagnosis of FPL. |
|---|
| Other data |
|---|
| OCA16. Annotation of the output in English | Feline panleukopenia is a contagious viral disease caused by the feline panleukopenia virus (FPV). A closely related pathogen is canine parvovirus (CPV), and amino acid substitutions in this virus allow it to acquire a feline host range. In feline hosts, the disease induced by CPV manifests with similar symptoms to those caused by FPV or milder ones, leading to its underdiagnosis. The aim of this study was to determine the presence of CPV type 2 (CPV-2) in cats with clinical symptoms of
panleukopenia and to assess the use of commercial CPV antigen tests for the clinical diagnosis of FPV. Samples from 59 cats from central Slovakia were included in the study. Rectal swabs were collected and clinically tested for parvovirus infection using a commercial antigen test. Antigen-positive samples were confirmed by PCR targeting the viral VP2
gene. The sequences of the PCR products were established with the Sanger method. Although feline disease with CPV-2 was not confirmed, the CPV antigen test was able to detect FPV infection. |
|---|
| OCA17. List of maximum 5 most significant citations corresponding to the output | |
|---|
| OCA18. Characteristics of the output's impact on socio-economic practice | This study provides baseline epidemiological data
for future prevention and control measures against
parvovirus infection and highlights the need for cat
vaccination programmes against feline panleukopenia |
|---|
| OCA19. Characteristics of the output and related activities' impact on the educational process | The knowledge gained from this work will be presented in the teaching process of the Infectious Diseases II course. |
|---|
